NASDAQ: OTLK · Biotechnology
Over the past week, Outlook Therapeutics (OTLK) drew about 56 mentions across Reddit, X and news, and the read is an Adanos Hold. The crowd averages 55% bullish but is deeply split: News runs 100% bullish while Reddit sits at just 31%. Wall Street is more cautious, with 2 of 4 analysts rating OTLK a buy.
“OTLK is trending because FDA Approval has been granted, with optimism around regulatory progress offset by concern about trade resumption timing.”Adanos /explain
Wall Street’s 50% buy share sits next to a crowd that ranges from Reddit at 31% to News at 100%. No other tracker puts the two side by side.
Across 4 analysts the consensus is a Buy: 2 buy calls against 0 sell, with an average 12-month price target of $5.50.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits above the neutral line, momentum is cooling and the 3 sources disagree sharply, so the read is Hold rather than a clear buy or sell.
The crowd runs 5 points hotter than the 50% analyst buy share, retail is ahead of the Street here. The split is inside the crowd: News reads 100% bullish while Reddit sits at 31%, a 69-point spread that single-source trackers miss.
Over the 30-day window, Outlook Therapeutics (OTLK) buzz held moderate around 43.6 while the price drifted down 16.9% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 10.8M shares. Updated Jul 27, 2026. Over the last 7 trading days, OTLK lost 3.8%. Buzz activity in the recent week averaged 28.7 and was variable, swinging between 4.1 and 43.6. Recent volume is running above the 30-day average, suggesting heightened trading interest. Daily crowd sentiment leaned bullish on 12 of the 19 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Buzz, bullish share, the loudest item and the positive / neutral / negative split for every tracked source over the last 7 days.
No Polymarket data for this stock this week.
Query sentiment for OTLK and 1000+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live OTLK sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Jul 27, 2026.
Based on aggregated sentiment from Reddit, X and News sources, Outlook Therapeutics (OTLK) currently carries an Adanos hold signal with 53/100 conviction. The current cross-source average reads 55% bullish across 3 active sources. Those sources contribute 56 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Outlook Therapeutics (OTLK) is fairly quiet with 49 mentions across 8 tracked subreddits. The tone is 31% bullish with falling 3-day activity momentum, suggesting cooling attention.
The crowd reads split on Outlook Therapeutics (OTLK), averaging 55% bullish across 3 tracked sources over the last 7 days. The two ends of the range are News at 100% bullish and Reddit at 31%, a 69-point spread. On the professional side, 2 of 4 analysts rate OTLK a buy.
Of the 4 analysts covering Outlook Therapeutics (OTLK), 2 rate it a buy, 2 a hold and 0 a sell, for a buy consensus. The average price target is $5.50. The crowd is the more bullish of the two, averaging 55%.
Outlook Therapeutics (OTLK) sentiment is mixed across all 3 tracked sources. X reads 33% bullish, News reads 100% bullish and reddit coverage is the most negative at 31% bullish. The combined signal points to broad mixed pressure with 53/100 conviction.
Social sentiment data shows consistently mixed discussion around Outlook Therapeutics (OTLK). All 3 tracked sources lean in different directions, with reddit being the most bearish at 31% bullish. 3-day activity momentum is falling across Reddit and News. The hold signal carries 53/100 conviction.
Reddit is the dominant discussion channel with 49 mentions (88% of total volume). News contributes 4 mentions and X contributes 3 mentions. Sentiment is mixed across all sources.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. OTLK's hold signal at 53/100 conviction reflects consistently mixed sentiment across 3 tracked sources. It is a research shortcut, not financial advice.
The OTLK sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
These stocks share a comparable sentiment profile to Outlook Therapeutics with similar bullish ratios, signal direction and discussion volume. All 6 peers carry hold signals, pointing to broad mixed pressure rather than an OTLK-specific issue.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key